531 related articles for article (PubMed ID: 26017164)
1. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
2. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE
Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711
[TBL] [Abstract][Full Text] [Related]
3. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.
Miró G; Oliva G; Cruz I; Cañavate C; Mortarino M; Vischer C; Bianciardi P
Vet Dermatol; 2009 Oct; 20(5-6):397-404. PubMed ID: 20178476
[TBL] [Abstract][Full Text] [Related]
4. Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.
Miró G; Gálvez R; Fraile C; Descalzo MA; Molina R
Parasit Vectors; 2011 Apr; 4():52. PubMed ID: 21489241
[TBL] [Abstract][Full Text] [Related]
5. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
6. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol.
Torres M; Bardagí M; Roura X; Zanna G; Ravera I; Ferrer L
Vet J; 2011 Jun; 188(3):346-51. PubMed ID: 20594876
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the reverse to normal of clinico-pathological findings and the disease free interval time using four different treatment protocols for canine leishmaniosis in an endemic area.
Paradies P; Sasanelli M; Amato ME; Greco B; De Palo P; Lubas G
Res Vet Sci; 2012 Oct; 93(2):843-7. PubMed ID: 22296941
[TBL] [Abstract][Full Text] [Related]
8. Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
de Morais-Teixeira E; Aguiar MG; Soares de Souza Lima B; Ferreira LA; Rabello A
J Antimicrob Chemother; 2015 Dec; 70(12):3283-90. PubMed ID: 26346991
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and clinical management of canine leishmaniosis by general veterinary practitioners: a questionnaire-based survey in Portugal.
Monteiro M; Prata S; Cardoso L; Pereira da Fonseca I; Leal RO
Parasit Vectors; 2021 Jun; 14(1):306. PubMed ID: 34099039
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
Dias ÁFLR; Ayres EDCBS; de Oliveira Martins DT; Maruyama FH; de Oliveira RG; de Carvalho MR; Almeida ADBPF; Teixeira ALS; Mendonça AJ; Sousa VRF
Exp Parasitol; 2020 Oct; 217():107947. PubMed ID: 32628971
[TBL] [Abstract][Full Text] [Related]
11. Leishmania infantum-specific IFN-γ production in stimulated blood from dogs with clinical leishmaniosis at diagnosis and during treatment.
Martínez-Orellana P; Marí-Martorell D; Montserrat-Sangrà S; Ordeix L; Baneth G; Solano-Gallego L
Vet Parasitol; 2017 Dec; 248():39-47. PubMed ID: 29173539
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis.
Mateo M; Maynard L; Vischer C; Bianciardi P; Miró G
Parasitol Res; 2009 Jul; 105(1):155-62. PubMed ID: 19238439
[TBL] [Abstract][Full Text] [Related]
13. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
[TBL] [Abstract][Full Text] [Related]
14. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
[TBL] [Abstract][Full Text] [Related]
15. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
[TBL] [Abstract][Full Text] [Related]
16. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
[TBL] [Abstract][Full Text] [Related]
17. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.
Dos Santos CCP; Ramos GS; De Paula RC; Faria KF; Moreira POL; Pereira RA; Melo MN; Tafuri WL; Demicheli C; Ribeiro RR; Azevedo EG; Do Monte-Neto R; Da Silva SM; Frézard F
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32284386
[TBL] [Abstract][Full Text] [Related]
19. TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment.
Montserrat-Sangrà S; Alborch L; Ordeix L; Solano-Gallego L
Vet Parasitol; 2016 Sep; 228():172-179. PubMed ID: 27692322
[TBL] [Abstract][Full Text] [Related]
20. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
Steuber S; Moritz A; Schirrmann I; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
